The Jinshan facility is dedicated to the manufacture of small molecule innovative APIs and advanced intermediates, from kilo to metric ton scale – from preclinical an...

The WHO South-East Asia Region records about 37 million births every year, of them over 88% children are now getting three doses of diphtheria, pertussis and tetanus ...

The investment will tap into the rapidly growing $100 billion Indian healthcare market LeapFrog Investments ("LeapFrog"), the leading investor in companies that deli...

Under the terms of the MoU, the AEI will provide its professional and clinical trial expertise to Novotech managed studies. Asia-Pacific specialist CRO Novotech has...

A flurry of Phase 3 data this year from Roche's immmunotherapy Tecentriq has so far proved insufficient to erase the lead of Merck & Co.'s rival Keytruda in fi...